Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia · Delayed Price · Currency is SAR 26.30
-0.04 (-0.15%)
Oct 15, 2026, 3:19 PM AST
TADAWUL:4009 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,421 | 2,997 | 6,323 | 8,127 | 2,342 | 2,913 | |
Market Cap Growth | -54.73% | -52.61% | -22.20% | 246.95% | -19.59% | -9.70% |
Enterprise Value | 4,877 | 5,376 | 8,804 | 10,537 | 4,540 | 4,755 |
Last Close Price | 26.30 | 32.05 | 67.04 | 86.16 | 24.83 | 30.88 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 9.93 | 22.42 | 476.99 | 31.16 | 169.35 |
Forward PE | 13.03 | 10.52 | 22.96 | 32.62 | 24.51 | 27.34 |
PS Ratio | - | 0.97 | 2.19 | 3.06 | 1.09 | 1.56 |
PB Ratio | 1.51 | 1.56 | 3.78 | 5.95 | 1.66 | 2.25 |
P/TBV Ratio | 1.64 | 1.65 | 4.00 | 6.31 | 1.73 | 2.33 |
P/FCF Ratio | - | 33.51 | 21.42 | - | - | - |
P/OCF Ratio | 4.52 | 5.50 | 8.26 | 42.53 | 30.81 | 38.02 |
PEG Ratio | 3.26 | 1.26 | 0.74 | 1.16 | 1.35 | 1.35 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | 1.73 | 3.05 | 3.97 | 2.11 | 2.54 |
EV/EBITDA Ratio | - | 8.96 | 14.00 | 21.17 | 16.82 | 25.68 |
EV/EBIT Ratio | - | 13.88 | 19.97 | 32.53 | 32.35 | 87.67 |
EV/FCF Ratio | - | 60.10 | 29.83 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.55 | 1.32 | 1.47 | 1.82 | 1.59 | 1.52 |
Debt / EBITDA Ratio | - | 4.10 | 3.81 | 4.86 | 7.87 | 10.12 |
Debt / FCF Ratio | - | 28.44 | 8.35 | - | - | - |
Net Debt / Equity Ratio | 1.50 | 1.31 | 1.44 | 1.79 | 1.58 | 1.50 |
Net Debt / EBITDA Ratio | - | 4.20 | 3.84 | 4.90 | 8.24 | 10.47 |
Net Debt / FCF Ratio | - | 28.15 | 8.18 | -63.35 | -12.82 | -5.70 |
Asset Turnover | - | 0.59 | 0.56 | 0.55 | 0.51 | 0.49 |
Inventory Turnover | - | 29.76 | 25.16 | 14.69 | 9.71 | 8.20 |
Quick Ratio | - | 1.40 | 1.58 | 1.10 | 1.01 | 0.98 |
Current Ratio | - | 1.55 | 1.72 | 1.19 | 1.20 | 1.15 |
Return on Equity (ROE) | - | 17.18% | 18.68% | 1.48% | 5.30% | 0.91% |
Return on Assets (ROA) | - | 4.57% | 5.37% | 4.20% | 2.07% | 0.90% |
Return on Invested Capital (ROIC) | - | 8.63% | 10.22% | 0.94% | 3.60% | 1.10% |
Return on Capital Employed (ROCE) | - | 9.70% | 11.40% | 10.80% | 4.90% | 2.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | 10.07% | 4.46% | 0.21% | 3.21% | 0.59% |
FCF Yield | -0.71% | 2.99% | 4.67% | -0.47% | -7.41% | -11.67% |
Dividend Yield | 1.90% | 1.54% | 0.73% | - | - | - |
Payout Ratio | - | 15.24% | - | - | - | - |
Total Shareholder Return | 1.90% | 1.54% | 0.73% | - | - | - |